ChemoCentryx
CCXI
#3692
Rank
S$4.78 B
Marketcap
S$66.53
Share price
0.00%
Change (1 day)
31.50%
Change (1 year)

Market capitalization of ChemoCentryx (CCXI.defunct)

Last known market cap: S$4.78 Billion

On November 25, 2022 ChemoCentryx had a market cap of S$4.78 Billion. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of ChemoCentryx from 2012 to 2022

End of year Market Cap

Year Marketcap Change
2022S$5.01 B45.41%
2021S$3.44 B-39.2%
2020S$5.66 B76.52%
2019S$3.21 B325.42%
2018S$0.75 B94.53%
2017S$0.38 B-24.2%
2016S$0.51 B1.13%
2015S$0.50 B29.12%
2014S$0.39 B24.62%
2013S$0.31 B-35.31%
2012S$0.48 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
S$868.24 B 18,046.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
S$214.75 B 4,388.32%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
S$663.31 B 13,763.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
S$321.09 B 6,610.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
S$48.84 B 920.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$468.36 B 9,688.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$163.34 B 3,314.00%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
S$131.95 B 2,657.88%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
S$64.06 B 1,238.90%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel